Read More Pharma Industry News Sagent Pharmaceuticals and Qilu Pharmaceutical sign $4.5bn injectable drug deal to boost U.S. hospital supply access Sagent Pharmaceuticals signs $4.5B deal with Qilu Pharmaceutical to boost U.S. access to complex injectable drugs, improving affordability and supply resilience. byPallavi MadhirajuJuly 8, 2025